Literature DB >> 29149550

A promising on-demand treatment option for bleeding events in haemophilia patients with inhibitors.

Amy D Shapiro1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29149550     DOI： 10.1111/hae.13345

Source DB:  PubMed          Journal:  Haemophilia        ISSN： 1351-8216            Impact factor:   4.287


× No keyword cloud information.
  1 in total

1.  Exploratory in vitro evaluation of thrombin generation of eptacog beta (recombinant human fviia) and emicizumab in congenital haemophilia A plasma.

Authors:  Jerry Grandoni; Véronique Duretz; Daniel Bonzo; Sean Evans; Jean-Luc Plantier
Journal:  Haemophilia       Date:  2021-02-06       Impact factor: 4.287
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.